Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Barclays PLC (“Barclays” or the “Company”) (NYSE: BCS) on behalf of Barclays stockholders. Our investigation concerns whether Barclays has violated the federal securities laws and/or engaged in other unlawful business practices.

Click here to participate in the action.

On March 28, 2022, Barclays disclosed that it had sold $15.2 billion more structured notes and exchange-traded notes than it had registered. Barclays would repurchase the affected securities at their original price, resulting in approximately $592 million in losses.

On this news, Barclays’ share fell $0.96, or 10.6%, to close at $8.09 per share on March 28, 2022, thereby injuring investors.

If you purchased or otherwise acquired Barclays shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Alexandra Raymond by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220331006072/en/